Phospho-MAP3K5 (Ser83) Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

The Phospho-MAP3K5 (Ser83) Antibody is a specialized tool for detecting the phosphorylation status of MAP3K5 (Mitogen-Activated Protein Kinase Kinase Kinase 5), also known as Apoptosis Signal-Regulating Kinase 1 (ASK1), at serine residue 83. This phosphorylation event plays a critical role in modulating ASK1’s activity in stress-induced apoptosis and immune signaling pathways .

Biological Context of MAP3K5/ASK1

MAP3K5/ASK1 is a serine/threonine kinase central to the MAPK signaling cascade, activating downstream kinases MKK4/7 and subsequently JNK/p38 under oxidative stress, cytokine stimulation, or DNA damage . Its activity is tightly regulated by post-translational modifications (PTMs), including phosphorylation and ubiquitination. Phosphorylation at Ser83 (alongside Ser967 and Ser1034) suppresses ASK1’s pro-apoptotic function by promoting interactions with 14-3-3 proteins, which sequester ASK1 in the cytoplasm .

Mechanism of Action

  • Inactivation via Ser83 Phosphorylation: Phosphorylation at Ser83 by kinases such as AKT1, AKT2, or PIM1 promotes 14-3-3 protein binding, inhibiting ASK1’s kinase activity and downstream apoptosis .

  • Cross-Regulation with Other PTMs: Dephosphorylation at Ser83 (alongside Thr845 phosphorylation) is essential for ASK1 activation under oxidative stress .

Disease Relevance

  • Cancer: ASK1’s inactivation via Ser83 phosphorylation is implicated in melanoma progression. Mutant ASK1 (e.g., R256C) shows attenuated pro-apoptotic signaling and increased tumor cell survival, particularly in BRAF-wild-type melanomas .

  • Immune Response: ASK1 mediates innate immune signaling against pathogens, with phosphorylation dynamics influencing inflammatory outcomes .

Western Blot Applications

  • Positive Controls: Detected in HEK-293T cells and λ phosphatase-treated HEK-293T lysates .

  • Key Observations: Reduced phospho-ASK1 (Ser83) correlates with ASK1 activation in melanoma cells under stress conditions .

Functional Studies

Study ModelKey Insight
Melanoma Cell LinesASK1 Ser83 phosphorylation attenuates JNK/p38 activation, promoting survival .
HEK-293T TransfectionMutant ASK1 (R256C) exhibits reduced MKK4 phosphorylation and enhanced Trx binding .

Technical Considerations

  • Cross-Reactivity: Validated for human samples; reactivity with other species requires verification .

  • Optimization: Titration is critical due to variability in phosphorylation levels across experimental conditions .

Product Specs

Form
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
We typically dispatch products within 1-3 business days of receiving your order. Delivery times may vary depending on the shipping method and location. Please contact your local distributor for specific delivery time information.
Synonyms
Apoptosis signal regulating kinase 1 antibody; Apoptosis signal-regulating kinase 1 antibody; ASK 1 antibody; ASK-1 antibody; ASK1 antibody; M3K5 antibody; M3K5_HUMAN antibody; MAP/ERK kinase kinase 5 antibody; MAP3K5 antibody; MAPK/ERK kinase kinase 5 antibody; MAPKKK5 antibody; MEK kinase 5 antibody; MEKK 5 antibody; MEKK5 antibody; Mitogen activated protein kinase kinase kinase 5 antibody; Mitogen-activated protein kinase kinase kinase 5 antibody
Target Names
Uniprot No.

Target Background

Function
Phospho-MAP3K5 (Ser83) Antibody targets a serine/threonine kinase that plays a crucial role in the MAP kinase signal transduction pathway. This kinase is essential for cellular responses to environmental changes and mediates signaling for cell fate decisions, including differentiation and survival. It plays a pivotal role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is a critical component of the innate immune response, essential for defending against a wide range of pathogens. It mediates signal transduction of various stressors, including oxidative stress and receptor-mediated inflammatory signals such as tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Upon activation, MAP3K5/ASK1 acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade, phosphorylating and activating MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6, and MAP2K7/MKK7. These MAP2Ks subsequently activate p38 MAPKs and c-jun N-terminal kinases (JNKs), which, in turn, control the transcription factors activator protein-1 (AP-1).
Gene References Into Functions
  1. Advanced glycation end products significantly activated ASK1, MKK3, and MKK6, leading to p38 MAPK activation and subsequent upregulation of the fibrotic response in human coronary smooth muscle cells. PMID: 30305582
  2. Transcriptional upregulation of ASK1 defines a metabolically detrimental obese sub-phenotype. PMID: 28702328
  3. Knockdown of miR-20a enhanced the sensitivity of colorectal cancer cells to cisplatin through the ROS/ASK1/JNK pathway. PMID: 29940575
  4. These findings provide insight into the positive regulation of Akt signaling through P2Y12 phosphorylation, as well as MAPK signaling in platelets by ASK1. PMID: 28753204
  5. Cold stress-induced ferroptosis involves the ASK1-p38 pathway. PMID: 28887319
  6. TRIM48 promotes ASK1 activation and cell death through ubiquitination-dependent degradation of the ASK1-negative regulator PRMT1. PMID: 29186683
  7. These findings indicate that chaetocin arrests the cell cycle and induces apoptosis by regulating the reactive oxygen species-mediated ASK-1/JNK signaling pathways. PMID: 28849240
  8. These findings provide evidence that ASK-1 expression is regulated by SLC35F2, which exerts its oncogenic effect on papillary thyroid carcinoma progression through activation of TGFBR-1 and ASK-1. PMID: 29274137
  9. Co-administration of acetaminophen and 5'-AMP significantly ameliorated APAP-induced hepatotoxicity in mice. This effect was triggered by attenuating apoptosis signal-regulated kinase 1 (ASK1) methylation and increasing ubiquitination-mediated ASK1 protein degradation. PMID: 28031524
  10. The anti-cancer mechanism for AgNPs may involve activation of the ASK1-JNK/p38-Caspase-3 pathway. PMID: 29381295
  11. TRAF1 functions as a positive regulator of insulin resistance, inflammation, and hepatic steatosis, dependent on the activation of the ASK1-P38/JNK axis. PMID: 26860405
  12. LRRK2-induced apoptosis was suppressed by ASK1 inhibition in neuronal stem cells derived from patients with Parkinson's disease (PD). These results clearly indicate that LRRK2 acts as an upstream kinase in the ASK1 pathway and plays an important role in the pathogenesis of PD. PMID: 28888991
  13. Apoptosis signal-regulating kinase 1 (ASK1) expression was dramatically suppressed and correlated with hepatocyte nuclear factor 4alpha (HNF4alpha) levels in hepatocellular carcinoma (HCC) tissues. PMID: 27050273
  14. ASK1 phosphorylated and stabilized TLX, leading to the induction of HIF-1alpha and its downstream VEGF-A in an Akt-dependent manner. PMID: 27890558
  15. CD40 activation resulted in the down-regulation of Thioredoxin (Trx)-1 to permit ASK1 activation and apoptosis. Although soluble receptor agonist alone could not induce death, combinatorial treatment incorporating soluble CD40 agonist and pharmacological inhibition of Trx-1 was functionally equivalent to the signal triggered by mCD40L. PMID: 27869172
  16. These results suggest that platelet Ask1 plays an important role in regulating hemostasis and thrombosis. PMID: 28028021
  17. Of the two catalytic cysteines of TRX1, residue C32 is responsible for the high-affinity binding of TRX1 to the ASK1-TRX-binding domain in reducing conditions. PMID: 27588831
  18. Shotgun mass spectrometry and manual validation identified 12 distinct ASK1 phosphosites. Targeted parallel reaction monitoring assays were used to track the phosphorylation dynamics of each confirmed site in response to treatment. PMID: 27989136
  19. Phosphorus NMR and time-resolved tryptophan fluorescence measurements suggest that 14-3-3zeta interacts with the kinase domain of ASK1 in close proximity to its active site, indicating that this interaction might block its accessibility and/or affect its conformation. PMID: 27514745
  20. The ASK1 MAP kinase signaling cascade is an important regulator of chondrocyte terminal differentiation. PMID: 26405834
  21. Pretreatment with IRE1 agonist tunicamycin or JNK agonist anisomycin attenuated the effect of psoralen on osteoporotic osteoblasts. Psoralen inhibited apoptosis of osteoporotic osteoblasts by regulating the IRE1-ASK1-JNK pathway. PMID: 28349059
  22. Our results suggest that GSK-3beta is a key factor involved in ASK1 activation and reactive oxygen species-induced cell death. PMID: 27221474
  23. These data show that miRNA-mediated down-regulation of ASK1 protects mesenchymal stem cells during post-transplantation, leading to an increase in the efficacy of MSC-based cell therapy. PMID: 27775615
  24. Cross-talk between arginine methylation and serine phosphorylation in ASK1. PRMT5 is an ASK1-binding protein. PRMT5 mediates arginine methylation of ASK1. PMID: 26912789
  25. Results suggest that baicalein-mediated ASK1/JNK activation regulates the mitochondria-dependent apoptosis pathway through the up-regulation of TAp63 and down-regulation of NF-kappaB and CD74/CD44 in B-cell malignancies. PMID: 26694167
  26. The effects of curcumin and ABT-737 on HCC cells were investigated. It was found that curcumin markedly enhanced the antitumor effects of ABT-737 on HepG2 cells and activates the ROS-ASK1-c-Jun N-terminal kinase pathway. PMID: 26707143
  27. ASK1 signaling regulates brown and beige adipocyte function. PMID: 27045525
  28. These results implicate the TNF/TRAF2/ASK1/p38 kinase pathway in modulating the risk of pulmonary complications. PMID: 26165383
  29. The present findings support the notion that ROR1 sustains lung adenocarcinoma survival, at least in part, through direct physical interaction with ASK1. PMID: 26661061
  30. Together, we suggest that 4SC-202 activates the ASK1-dependent mitochondrial apoptosis pathway to potently inhibit human HCC cells. PMID: 26773495
  31. Data show that the MAPKKK6 ASK2, a modulator of MAPKKK5 ASK1 signaling, was essential for ASK1-dependent apoptosis but not for inducing interferon-beta (IFNB) expression. PMID: 26243192
  32. The expression of ASK1 is correlated with the level of claudin-6 in cervical carcinoma cells and tissues. PMID: 26191261
  33. ASK1 stabilizes APOBEC3G and binds HIV-1 Vif, disrupting the assembly of the Vif-ubiquitin ligase complex, thus restoring the antiviral activity of APOBEC3g. PMID: 25901786
  34. Data indicate that ASK1 expression is regulated by MiR-19a by targeting specific sites in the 3' untranslated region of its mRNA. PMID: 25982447
  35. Findings suggest that methyl isocyanate inhibits angiogenesis by inducing mitogen-activated protein kinase kinase kinase 5 ASK1-JNK-dependent endothelial cell death. PMID: 25068797
  36. TNF-alpha-induced ASK1-p38/JNK pathway is an important mediator of cytokine synthesis and enhanced expression of adhesion molecules in rheumatoid arthritis and is inhibited by thymoquinone. PMID: 26134265
  37. Cyclophilin A regulates JNK/p38-MAPK signaling through its physical interaction with ASK1. PMID: 26095851
  38. Knockdown of IRE1alpha by siRNA dramatically abrogated CXC195-induced activation of TRAF2, ASK, and JNK, formation of an IRE1alpha-TRAF2-ASK1 complex, and caspase- and mitochondrial-dependent apoptosis in T24 cells. PMID: 25797626
  39. Because the phosphorylation site mutants of NR4A2 cannot rescue the cell death-promoting activity, ASK1-p38 pathway-dependent phosphorylation and subsequent cytoplasmic translocation of NR4A2 may be required for oxidative stress-induced cell death. PMID: 25752609
  40. Collectively, these data reveal that activation of the PI3K/Akt pathway limits JNK-mediated apoptosis by phosphorylating and inactivating ASK1 during human enterovirus 71 infection. PMID: 25116390
  41. Siah1 is a substrate of ASK1 for activation of the GAPDH-Siah1 oxidative stress signaling cascade. PMID: 25391652
  42. TNF-signaling dependence of ASK1-mediated apoptosis in melanoma cells. PMID: 24574456
  43. Data show that ASK1 is critical for IFN gamma-induced DAPK1 via ATF6 recruitment. PMID: 25135476
  44. Apoptosis signal-regulating kinase 1 has a role in chondrosarcoma cell apoptosis along with endoplasmic reticulum stress due to FPipTB. PMID: 21594902
  45. Data suggest that degradation of ASK1 mediated by Roquin-2 is an evolutionarily conserved mechanism required for the appropriate regulation of stress responses, including pathogen resistance and cell death. PMID: 24448648
  46. It is activated in response to various stresses, such as reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress, and plays pivotal roles in a wide variety of cellular responses, including cell death, differentiation, and inflammation. (review) PMID: 24912301
  47. Data indicate that the ASK1-FoxO3a-TRADD-caspase 8 pathway is present in neural tube defects (NTDs)-affected tissues. PMID: 23982205
  48. MAP3K5 R256C mutation revealed attenuation of MKK4 activation through increased binding of the inhibitory protein thioredoxin (TXN/TRX-1/Trx), resulting in increased proliferation and anchorage-independent growth of melanoma cells. PMID: 24008424
  49. Identification of the domain through which HIV-1 Nef interacts with ASK1 and inhibits its function. PMID: 23799149
  50. In gastric epithelial cells, H. pylori activates ASK1 in a reactive oxygen species- and cag pathogenicity island-dependent manner, and ASK1 regulates sustained JNK activation and apoptosis induced by H. pylori. PMID: 24082073
Database Links

HGNC: 6857

OMIM: 602448

KEGG: hsa:4217

STRING: 9606.ENSP00000351908

UniGene: Hs.186486

Protein Families
Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase kinase subfamily
Subcellular Location
Cytoplasm. Endoplasmic reticulum. Note=Interaction with 14-3-3 proteins alters the distribution of MAP3K5/ASK1 and restricts it to the perinuclear endoplasmic reticulum region.
Tissue Specificity
Abundantly expressed in heart and pancreas.

Q&A

What is MAP3K5/ASK1 and what cellular pathways does it regulate?

MAP3K5 (Mitogen-activated protein kinase kinase kinase 5), also known as ASK1 (Apoptosis signal-regulating kinase 1), is a serine/threonine kinase that functions as an essential component of the MAP kinase signal transduction pathway. It mediates crucial signaling for cellular responses to environmental changes and determination of cell fate, including differentiation and survival. MAP3K5/ASK1 plays a critical role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation . It serves as a key regulator in the innate immune response, which is essential for host defense against a wide range of pathogens. Additionally, MAP3K5 mediates signal transduction of various stressors including oxidative stress and receptor-mediated inflammatory signals such as tumor necrosis factor (TNF) and lipopolysaccharide (LPS) .

When activated, MAP3K5/ASK1 functions as an upstream activator of two major signal transduction cascades:

  • The MKK/JNK (MAP kinase kinase/c-Jun N-terminal kinase) cascade

  • The p38 MAPK signal transduction cascade

This activation occurs through phosphorylation of several MAP kinase kinases including MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6, and MAP2K7/MKK7, which in turn activate JNKs and p38 MAPKs to control transcription factors like activator protein-1 (AP-1) .

What is the significance of Serine 83 phosphorylation in MAP3K5/ASK1 regulation?

Phosphorylation at Serine 83 (Ser83) represents a critical post-translational modification that regulates MAP3K5/ASK1 activity and function. This specific modification site is located within the N-terminal region (amino acids 1-100) of the protein . Ser83 phosphorylation serves as a regulatory mechanism that modulates the kinase activity of MAP3K5/ASK1 in response to various cellular stimuli and stress conditions.

The state of Ser83 phosphorylation can determine whether MAP3K5/ASK1 activates downstream signaling cascades that lead to cell survival or apoptosis. This phosphorylation event represents one of several regulatory mechanisms that ensure appropriate cellular responses to environmental stressors and signaling inputs. Understanding the dynamics and regulation of Ser83 phosphorylation provides critical insights into how cells coordinate stress responses and maintain homeostasis under challenging conditions.

How does Ser83 phosphorylation differ from other phosphorylation sites on MAP3K5/ASK1?

MAP3K5/ASK1 contains multiple phosphorylation sites that collectively form a complex regulatory network controlling its activity and function. While Ser83 is a key regulatory site, other phosphorylation sites such as Ser966 serve distinct regulatory functions . The specific combination of phosphorylated residues creates a phosphorylation signature that determines MAP3K5/ASK1 activity status and downstream signaling outcomes.

Phosphorylation SiteLocationFunctionDetection Methods
Serine 83 (Ser83)N-terminal region (aa 1-100)Regulatory function affecting kinase activityWB (1:500-1:2000), IHC (1:50-1:300), ELISA (1:20000)
Serine 966 (Ser966)Internal regulatory domainDistinct regulatory functionWB (1:500-1:2000), IHC (1:100-1:300)

Different phosphorylation sites may respond to different upstream signals and kinases, enabling MAP3K5/ASK1 to integrate multiple inputs from various signaling pathways. The temporal dynamics of phosphorylation at these sites can also differ, allowing for precise temporal control of MAP3K5/ASK1 activity during cellular responses to stress and other stimuli.

What are the primary applications for Phospho-MAP3K5 (Ser83) antibodies?

Phospho-MAP3K5 (Ser83) antibodies serve as essential tools for investigating the phosphorylation state of MAP3K5/ASK1 in various experimental contexts. Based on manufacturer specifications and research literature, these antibodies are validated for multiple applications:

  • Western Blot (WB): Enables detection and semi-quantitative analysis of Ser83-phosphorylated MAP3K5 in cell or tissue lysates, with recommended dilutions typically ranging from 1:500 to 1:2000 .

  • Immunohistochemistry (IHC): Allows visualization of the spatial distribution of phosphorylated MAP3K5 in tissue sections, with recommended dilutions typically between 1:50 and 1:300 .

  • Enzyme-Linked Immunosorbent Assay (ELISA): Provides quantitative measurement of phosphorylated MAP3K5 levels in complex samples, with recommended dilutions around 1:20000 .

These applications enable researchers to examine the phosphorylation status of MAP3K5 at Ser83 across different experimental conditions, cell types, and disease models, facilitating investigation of stress response pathways, apoptosis regulation, and immune signaling mechanisms.

What considerations are important for Western blot detection of phosphorylated MAP3K5?

Successful Western blot detection of phosphorylated MAP3K5 at Ser83 requires careful attention to several methodological aspects:

  • Sample Preparation: Rapid and appropriate sample handling is crucial to preserve phosphorylation status. Samples should be collected quickly and lysed in buffers containing phosphatase inhibitors to prevent dephosphorylation during processing .

  • Expected Molecular Weight: MAP3K5/ASK1 has a calculated molecular weight of approximately 155 kDa, which should be considered when analyzing Western blot results .

  • Antibody Selection and Validation: It is essential to use antibodies that specifically recognize the phosphorylated form of MAP3K5 at Ser83. According to manufacturer information, these antibodies detect endogenous levels of MAP3K5 only when phosphorylated at Ser83 .

  • Controls: Proper experimental design should include positive controls (such as lysates from cells treated with known inducers of Ser83 phosphorylation) and negative controls (such as phosphatase-treated samples or samples from cells with MAP3K5 knockdown) .

  • Quantification: For quantitative analysis, it is recommended to normalize phospho-MAP3K5 signal to total MAP3K5 levels to account for variations in protein expression between samples. This requires parallel blotting with an antibody recognizing total MAP3K5 regardless of phosphorylation status .

How can immunohistochemistry protocols be optimized for phospho-epitope detection?

Optimizing immunohistochemistry protocols for phospho-MAP3K5 (Ser83) detection requires addressing several challenges unique to phospho-epitopes:

  • Tissue Fixation and Processing: Phospho-epitopes are often sensitive to fixation conditions. Formalin/PFA-fixed paraffin-embedded sections are commonly used, but fixation time should be carefully controlled to preserve phosphorylation while achieving adequate tissue morphology .

  • Antigen Retrieval: Heat-induced epitope retrieval methods are typically necessary to unmask phospho-epitopes that may become obscured during fixation. The specific pH and buffer composition should be optimized for phospho-MAP3K5 detection .

  • Antibody Dilution: Manufacturers recommend dilutions ranging from 1:50 to 1:300 for IHC applications. Optimization experiments testing multiple dilutions are advisable for each specific tissue type and experimental condition .

  • Signal Amplification: Secondary detection systems may need enhancement for optimal visualization of phospho-signals, which can be relatively low abundance compared to total protein levels.

  • Validation: Parallel staining of serial sections with antibodies against total MAP3K5 helps confirm specificity and provides context for interpreting phosphorylation patterns. Additional validation approaches include the use of tissues known to exhibit differential phosphorylation of MAP3K5 at Ser83 .

How should experiments be designed to study MAP3K5/ASK1 phosphorylation dynamics?

Robust experimental design for studying MAP3K5/ASK1 phosphorylation dynamics should incorporate the following elements:

  • Temporal Analysis: Include multiple time points after stimulus application to capture the kinetics of phosphorylation and dephosphorylation events. MAP3K5/ASK1 activation often shows complex temporal patterns that can be missed with single time point measurements .

  • Dose-Response Relationships: Test multiple concentrations of stimuli (e.g., oxidative stress inducers, inflammatory cytokines) to determine threshold levels required for Ser83 phosphorylation and to characterize dose-dependent effects .

  • Multiple Detection Methods: Combine complementary approaches (e.g., Western blot, IHC, ELISA) to strengthen findings and overcome limitations of individual techniques .

  • Pathway Perturbation: Include experiments with specific inhibitors or activators of upstream regulators to establish causal relationships in signaling pathways leading to MAP3K5 Ser83 phosphorylation .

  • Genetic Approaches: Consider using gene editing techniques (CRISPR/Cas9) to generate Ser83 mutants (e.g., S83A to prevent phosphorylation or S83D/E to mimic constitutive phosphorylation) for functional studies .

  • Parallel Assessment of Multiple Phosphorylation Sites: Simultaneously monitor phosphorylation at different sites (e.g., Ser83 and Ser966) to understand their interdependence and relative contributions to MAP3K5/ASK1 regulation .

What positive and negative controls are essential when investigating MAP3K5 phosphorylation?

Rigorous control experiments are critical for reliable investigation of MAP3K5 phosphorylation:

Positive Controls:

  • Known Inducers: Treatments with established inducers of MAP3K5 Ser83 phosphorylation, such as specific oxidative stress conditions or TNF-α, can serve as positive controls .

  • Phospho-Mimetic Mutants: Cells expressing phospho-mimetic Ser83 variants can provide reference signals for phosphorylated states.

  • Validated Cell Lines: Human cell lines like 293T cells that have been verified to exhibit detectable phospho-MAP3K5 (Ser83) signals under appropriate conditions .

Negative Controls:

  • Phosphatase Treatment: Sample aliquots treated with phosphatases to remove phosphorylation can demonstrate signal specificity .

  • Blocking Peptides: Competition assays using the phospho-peptide immunogen can confirm antibody specificity .

  • Phospho-Deficient Mutants: Cells expressing S83A mutants that cannot be phosphorylated at this site provide important negative controls .

  • MAP3K5/ASK1 Knockdown/Knockout: Cells with reduced or eliminated MAP3K5 expression help validate signal specificity and establish background levels .

How can researchers validate the specificity of phospho-MAP3K5 (Ser83) antibody detection?

Validating antibody specificity is paramount for reliable phosphorylation studies. Multiple complementary approaches should be employed:

  • Antibody Pair Analysis: Using antibody pairs that recognize total MAP3K5 and phospho-MAP3K5 (Ser83) in parallel provides internal validation. The phospho-specific signal should represent a subset of the total MAP3K5 signal .

  • Peptide Competition: Pre-incubating the antibody with synthetic phosphopeptides corresponding to the Ser83 region should abolish specific signals if the antibody is truly phospho-specific .

  • Mutagenesis Studies: Comparing signals between wild-type MAP3K5 and S83A mutants provides definitive validation of phospho-specificity .

  • Phosphatase Controls: Treating samples with lambda phosphatase should eliminate phospho-specific signals while leaving total MAP3K5 signals intact .

  • Multiple Antibody Comparison: Using different phospho-MAP3K5 (Ser83) antibodies from different manufacturers or production lots can help confirm findings and identify potential antibody-specific artifacts .

What are common challenges in detecting phospho-MAP3K5 (Ser83) and their solutions?

Researchers frequently encounter several technical challenges when detecting phospho-MAP3K5 (Ser83):

ChallengePossible CausesSolutions
Weak or absent signalLow phosphorylation levels, rapid dephosphorylation during sample preparation, insufficient antibody concentrationInclude phosphatase inhibitors in lysis buffers, optimize stimulation conditions, increase antibody concentration or incubation time, use signal enhancement systems
High backgroundNon-specific antibody binding, inadequate blocking, excessive antibody concentrationOptimize blocking conditions, increase washing steps, titrate antibody concentration, use more specific detection systems
Multiple bands in Western blotProtein degradation, cross-reactivity, alternative splicing or post-translational modificationsUse freshly prepared samples with protease inhibitors, validate with alternative antibodies, compare with expected MW (155 kDa)
Inconsistent results between experimentsVariability in cell culture conditions, sample handling differences, antibody lot variationsStandardize experimental protocols, maintain consistent cell culture passage numbers, document antibody lot information
Discrepancies between different detection methodsMethod-specific artifacts, differential sensitivity, different epitope accessibilityUse complementary methods, validate findings across multiple approaches, consider the strengths and limitations of each method

How should researchers interpret changes in MAP3K5 Ser83 phosphorylation in the context of cellular signaling pathways?

Interpreting changes in MAP3K5 Ser83 phosphorylation requires consideration of the broader signaling context:

  • Relative Quantification: Express phospho-MAP3K5 (Ser83) levels relative to total MAP3K5 to account for changes in protein expression that might confound phosphorylation data .

  • Temporal Context: Consider the kinetics of phosphorylation changes, as transient versus sustained phosphorylation may have different functional implications for downstream signaling .

  • Multi-Site Phosphorylation: Interpret Ser83 phosphorylation in conjunction with other phosphorylation sites (e.g., Ser966) to develop a comprehensive understanding of MAP3K5 regulation .

  • Downstream Pathway Activation: Correlate Ser83 phosphorylation with the activation status of downstream targets in the MAP kinase cascade (e.g., phosphorylation of MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6, and MAP2K7/MKK7) to establish functional relevance .

  • Biological Outcomes: Connect phosphorylation changes to relevant cellular outcomes such as apoptosis, stress responses, or immune function to establish physiological significance .

What factors can lead to false positive or false negative results when detecting phospho-MAP3K5?

Several factors can compromise the reliability of phospho-MAP3K5 detection:

Potential False Positives:

  • Antibody cross-reactivity with similar phospho-epitopes on other proteins

  • Inadequate blocking leading to non-specific binding

  • Artifactual phosphorylation during sample handling due to stress-induced kinase activation

  • Signal amplification methods that enhance background along with specific signals

Potential False Negatives:

  • Rapid dephosphorylation during sample preparation if phosphatase inhibitors are inadequate

  • Epitope masking due to protein-protein interactions or conformational changes

  • Insufficient sensitivity of detection methods for low-abundance phosphorylation events

  • Improper storage conditions leading to antibody degradation (avoid freeze-thaw cycles)

To minimize these risks, researchers should implement rigorous controls, validate findings using multiple methodologies, and carefully optimize experimental conditions based on the specific requirements of phospho-MAP3K5 (Ser83) detection .

How can phospho-MAP3K5 (Ser83) analysis contribute to understanding disease mechanisms?

Phosphorylation of MAP3K5/ASK1 at Ser83 plays crucial roles in various pathological processes, making it a valuable target for disease-related research:

  • Neurodegenerative Disorders: MAP3K5/ASK1 activation is implicated in neuronal cell death pathways relevant to conditions like Alzheimer's and Parkinson's diseases. Monitoring Ser83 phosphorylation can provide insights into stress-response mechanisms in neurodegeneration .

  • Cancer Biology: Altered regulation of apoptotic pathways involving MAP3K5/ASK1 contributes to cancer development and therapy resistance. Phospho-MAP3K5 analysis in tumor samples can reveal disruptions in cell death signaling pathways .

  • Inflammatory Diseases: Given MAP3K5's role in innate immune responses, analyzing its phosphorylation status in inflammatory conditions can illuminate aberrant immune signaling mechanisms .

  • Cardiac Pathologies: MAP3K5/ASK1 mediates stress responses in cardiomyocytes. Phospho-specific analysis can help understand cellular adaptations in heart failure and ischemia-reperfusion injury .

Researchers can apply phospho-MAP3K5 (Ser83) analysis to patient-derived samples, disease models, and therapeutic intervention studies to elucidate pathogenic mechanisms and identify potential targets for therapeutic modulation .

What advanced technologies can enhance phospho-MAP3K5 detection and analysis?

Several cutting-edge approaches can extend the capabilities of traditional phospho-MAP3K5 detection methods:

  • Proximity Ligation Assay (PLA): This technique allows visualization of phospho-MAP3K5 in situ with enhanced specificity by detecting proximity between total MAP3K5 and phospho-Ser83 antibodies. PLA-based antibody pairs are commercially available for this purpose .

  • Mass Spectrometry-Based Phosphoproteomics: This approach enables unbiased, comprehensive analysis of phosphorylation events on MAP3K5/ASK1 and interacting partners, providing a systems-level view of signaling networks .

  • Single-Cell Phospho-Protein Analysis: Techniques like mass cytometry (CyTOF) or single-cell Western blotting allow examination of phospho-MAP3K5 heterogeneity within cell populations, revealing subpopulation-specific signaling dynamics .

  • Live-Cell Imaging with Phospho-Sensors: Genetically-encoded fluorescent biosensors designed to report MAP3K5 phosphorylation status enable real-time visualization of signaling dynamics in living cells .

  • Computational Modeling: Integration of phosphorylation data into mathematical models can predict system behaviors and generate testable hypotheses about MAP3K5 regulation in complex signaling networks .

How can researchers investigate the interplay between Ser83 phosphorylation and other regulatory mechanisms of MAP3K5/ASK1?

Understanding the complex regulation of MAP3K5/ASK1 requires investigation of multiple regulatory mechanisms and their interactions:

  • Multi-Site Phosphorylation Analysis: Simultaneous examination of phosphorylation at Ser83 and other sites (e.g., Ser966) can reveal synergistic or antagonistic relationships between different phosphorylation events .

  • Protein-Protein Interaction Studies: Investigating how Ser83 phosphorylation affects MAP3K5 binding to regulatory partners (e.g., 14-3-3 proteins, thioredoxin) provides insights into phosphorylation-dependent protein complex formation .

  • Post-Translational Modification Crosstalk: Analyzing interactions between phosphorylation and other modifications (e.g., oxidation, ubiquitination) can uncover complex regulatory networks controlling MAP3K5 activity .

  • Structural Biology Approaches: X-ray crystallography or cryo-EM studies of MAP3K5 in different phosphorylation states can reveal conformational changes induced by Ser83 phosphorylation that affect kinase activity .

  • Genetic Approaches: Creating cell lines with phospho-mimetic or phospho-deficient mutations at Ser83 and other regulatory sites allows dissection of site-specific functions in cellular responses to various stimuli .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.